Jebediah Ledell - 01 Dec 2021 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC.

Role
Chief Operating Officer
Signature
/s/ Danielle Holland, attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Dec 2021
Net transactions value
$0
Form type
4
Filing time
03 Dec 2021, 07:45:03 UTC
Next filing
17 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVEO Stock Option (right to buy) Award $0 +170,000 $0.000000 170,000 01 Dec 2021 Common Stock 170,000 $5.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was granted on December 1, 2021 and 25% of the options shall vest on December 1, 2022 and continue to vest in equal monthly installments thereafter until December 1, 2025.